These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 16010421
1. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Clement JH, Raida M, Sänger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A, Höffken K, Wölft S, Harris AL. Int J Oncol; 2005 Aug; 27(2):401-7. PubMed ID: 16010421 [Abstract] [Full Text] [Related]
2. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. Carcinogenesis; 2003 Sep; 24(9):1445-54. PubMed ID: 12819188 [Abstract] [Full Text] [Related]
3. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Schwalbe M, Sänger J, Eggers R, Naumann A, Schmidt A, Höffken K, Clement JH. Int J Oncol; 2003 Jul; 23(1):89-95. PubMed ID: 12792780 [Abstract] [Full Text] [Related]
9. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G. Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715 [Abstract] [Full Text] [Related]
11. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells. Horii Y, Takei H, Koibuchi Y, Horiguchi J, Maemura M, Iino Y, Morishita Y. Oncol Rep; 2006 May 15; 15(5):1191-5. PubMed ID: 16596185 [Abstract] [Full Text] [Related]
12. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen. Zhang M, Yan JD, Zhang L, Wang Q, Lü SJ, Zhang J, Zhu TH. Chin Med J (Engl); 2005 Oct 05; 118(19):1629-36. PubMed ID: 16232348 [Abstract] [Full Text] [Related]
13. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta]. Li Y, Chen N, Yu HJ, Dong XP, Huang QH. Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):544-8. PubMed ID: 16681885 [Abstract] [Full Text] [Related]
16. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. Ye L, Lewis-Russell JM, Kynaston H, Jiang WG. J Urol; 2007 Sep 28; 178(3 Pt 1):1086-91. PubMed ID: 17644136 [Abstract] [Full Text] [Related]
18. Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Raida M, Clement JH, Ameri K, Han C, Leek RD, Harris AL. Int J Oncol; 2005 Jun 28; 26(6):1465-70. PubMed ID: 15870857 [Abstract] [Full Text] [Related]
19. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells. Sugama R, Koike T, Imai Y, Nomura-Furuwatari C, Takaoka K. Bone; 2006 Feb 28; 38(2):206-14. PubMed ID: 16203197 [Abstract] [Full Text] [Related]
20. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Lai TH, Fong YC, Fu WM, Yang RS, Tang CH. Prostate; 2008 Sep 01; 68(12):1341-53. PubMed ID: 18512729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]